Management ChangeApr 16, 2026, 07:32 AM
Helus Pharma Appoints Dr. Ken Kramer as SVP, Medical Affairs
AI Summary
Helus Pharma (CYBIN INC.) announced the immediate appointment of Dr. Ken Kramer, PhD, as Senior Vice President, Medical Affairs. Dr. Kramer brings over 25 years of neuroscience experience, including leading medical affairs strategy and global launch readiness at companies like Bristol Myers Squibb and Karuna Therapeutics. CEO Michael Cola highlighted Dr. Kramer's deep experience and execution mindset as vital for scaling medical capabilities and advancing the company's pipeline, enhancing engagement with scientific and clinical communities.
Key Highlights
- Dr. Ken Kramer appointed Senior Vice President, Medical Affairs.
- Brings over 25 years of experience in neuroscience.
- Previously served as VP and Head of Medical Neuroscience at Bristol Myers Squibb.
- Led medical affairs at Karuna Therapeutics, supporting its acquisition.
- Holds a Ph.D. in Neuropharmacology from New York University.
Price Impact
More from HELP